Home > Insider Trading > Filing (0001610717-23-000363)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1512762	Coherus Biosciences Inc.	CHRS	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1420822	M Dennis Lanfear	C/O Coherus Biosciences, Inc. 333 Twin Dolphin Drive, Suite 600 Redwood City CA 94065	President & Ceo	No	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2023-11-22	41,000	$1.42	695,853	No	4	M	Direct
Common Stock	Acquisiton	2023-11-22	258,940	$1.42	954,793	No	4	M	Direct
Common Stock	Disposition	2023-11-22	223,100	$2.02	731,693	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2023-11-22	299,940	$0.00	299,940	$1.42

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0		2023-11-22	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	432,684	Indirect	By Trust
Common Stock	86,965	Indirect	By LLC

Footnotes

For part of the stock option, this represents a cash exercise-and-hold transaction where cash was paid by the Reporting Person for the exercise price and anticipated taxes.
For the remaining part of the stock option, this represents a cashless exercise-and-hold transaction where only enough shares were sold to cover the exercise price, anticipated taxes and broker's fee, and the remaining shares were held by the Reporting Person.
This transaction was executed in multiple trades at prices ranging from $2.000 to $2.055. The price reported above reflects the weighted average price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
These shares are held by the Lanfear Revocable Trust, dated January 27, 2004, as restated, of which Reporting Person is a trustee.
These shares are held by Lanfear Capital Advisors, LLC of which Reporting Person is President.
The underlying shares subject to the option vested and became exercisable in successive, equal monthly installments over four years measured from July 20, 2013.